AstraZeneca vaccine blood clot risk far lower than contraceptive pill and other medications walesonline.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from walesonline.co.uk Daily Mail and Mail on Sunday newspapers.
What women need to know about the AstraZeneca vaccine and blood clot concerns
As it s revealed that the majority of people who experienced blood clots in the UK are women, we pick through the science
All your questions answered
Credit: KAI PFAFFENBACH/ KAI PFAFFENBACH
In recent weeks, concerns have been raised about the safety of the AstraZeneca vaccine due to its potential link to blood clots.
Today, the Medicines and Healthcare products Regulatory Agency (MHRA) announced that people under the age of 30 will be offered a Pfizer or Moderna vaccine instead of an AstraZeneca jab, after the regulator found a possible link to blood clots in young people.
Australians are more likely to get blood clots from taking the pill or flying long haul than getting AstraZeneca s Covid-19 vaccine, studies show.
Prime Minister Scott Morrison and the state premiers have all backed the vaccine while the Therapeutic Goods Administration has said the jab is safe for public use.
Their support for the AstraZeneca version - which most Australians will have - is despite British regulators advising young people be given a different vaccine.
Of the 18 million people vaccinated in Britain against the virus, the national regulator has reported blood clotting in 79 recipients - 19 of whom died.
A registered nurse receives an injection of the Covid-19 vaccine in Townsville, central Queensland in March. Of the 18million people vaccinated in Britain against the virus, the national regulator has reported blood clotting in 79 recipients - or one in 228,000
How AstraZeneca Blood Clot Risk Compares to Contraceptive Pill, Smoking, Long-Haul Flights
On 4/8/21 at 8:40 AM EDT
On Wednesday, the European Medicines Agency (EMA) stated that blood clots with low blood platelets should be listed as very rare side effects of the Oxford-AstraZeneca (AZ) COVID vaccine.
It came to its conclusion based on a review of 86 blood clotting cases reported in the EU drug safety database, 18 of which were fatal. Most of these cases were reported from the EU as well as the U.K., where roughly 25 million people have received the jab. The EMA added the benefits of the vaccine still outweigh the risks.
Live updates from Oxford Astrazeneca Covid vaccine safety briefing
Professor Jonathan Van-Tam is hosting a briefing with the UK s medicines regulator
The video will auto-play soon8Cancel
Play now
England’s deputy chief medical officer Professor Jonathan Van-Tam is hosting a briefing with the UK s medicines regulator following an investigation into the Oxford/AstraZeneca vaccine and potential links with blood clots.
The televised media briefing starts at 3pm – the same time the European Medicines Agency (EMA) is offering an update on whether it thinks there is a causal link between the jab and rare clots.
Prof Van-Tam will be joined by Dr June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA), Professor Sir Munir Pirmohamed, chairman of the Commission on Human Medicines, and Professor Wei Shen, chairman of the Joint Committee on Vaccination and Immunisation (JCVI).